Cardiac phosphodiesterase 5 (cGMP-specific) modulates β-adrenergic signaling in vivo and is down-regulated in heart failure

Hideaki Senzaki, Carolyn J. Smith, George J. Juang, Takayoshi Isoda, Sharon P. Mayer, Andreas Ohler, Nazareno Paolocci, Gordon F. Tomaselli, Joshua M. Hare, David A. Kass

Research output: Contribution to journalArticlepeer-review

187 Scopus citations

Fingerprint

Dive into the research topics of 'Cardiac phosphodiesterase 5 (cGMP-specific) modulates β-adrenergic signaling in vivo and is down-regulated in heart failure'. Together they form a unique fingerprint.

Medicine & Life Sciences

Agriculture & Biology

Chemical Compounds